Clinical Trial Update: Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Pyrazoloacridine in women with refractory metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrazoloacridine (pyrazoloacridine)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED